Detailed price information for Aim Immunotech Inc (AIM-A) from The Globe and Mail including charting and trades.

OCALA, Fla., Sept. 30, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has ...

This in turn suggests a coherent picture of the structural organization of many dsRNA viruses. We present structures of a type 5 CPV determined by cryo-EM, revealing striking similarities with ...

The new product reduces dsRNA by up to 85%, helping to develop safer, more potent mRNA therapeutics. CleanScribe RNA Polymerase is a novel DNA-dependent RNA polymerase that catalyzes the in vitro ...

The great thing about dsRNA and antisense oligonucleotides are that they are highly specific, meaning that they only affect the organism that it is intended to affect, since it is made to that ...

Discover Alnylam Pharmaceuticals' groundbreaking patent for RNAi agents targeting the Serpina1 gene, offering innovative treatments for liver disorders and beyond.

The Company’s lead product is a first-in-class investigational drug called Ampligen ® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in ...

Dicer also processes long dsRNA molecules into small interfering RNA (siRNA) duplexes. Only one strand of the miRNA:miRNA* duplex or the siRNA duplex is preferentially assembled into the RNA ...

Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applicationsREDWOOD CITY, Calif., Oct. 01, ...

August/2982024/chapter-2-biotechnology-and-its-applications.jpg" width="1200" height="675" /> CBSE 2024-25 Competency-Based ...

The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in ...

TriLink BioTechnologies and Alphazyme, both part of Maravai LifeSciences, have collaborated to launch CleanScribe™ RNA ...